Organogenesis Holdings Inc.

NASDAQ:ORGO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.85 +3.21%

+$0.08 today

Market cap
$110.75M
Beta
1.33
P/E (TTM)
-1086.7
EPS (TTM)
-$0.00
52W Low $2.04High $7.08

Volume 0.86M

Average 1.49M

ORGO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Organogenesis Holdings Inc.NASDAQ: ORGO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 127.8M shares rose 1.2% year over year, ahead of the -2.8% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at -0.9% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.2% holds above the trailing-twelve-month pace of -2.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
127.8M+0.7% QoQ
Last fiscal yearDec 2025
126.74M-3.7% YoY
LTMMar 2026
127.11M-2.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.2%——
1 year-3.7%——
3-year CAGR-0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
126.74M USD
Year-over-year change
-3.7%
4-year CAGR
-0.3%

Weighted Avg Shares vs competitors

How ORGO compares with its peers on the latest reported figures

  • ORGO's LTM Mar 2026 weighted avg shares of 127.11M shares is the 4th highest of the 11 companies compared; the peer median is 67.07M shares.
  • Its year-over-year change of -2.8% is the 10th highest of 11, against a peer median of +1.5%.
  • Over three fiscal years its annual growth of -0.9% compares with a peer median of +3.1%.
ORGO Competitors Peer median
Weighted Avg Shares for ORGO and competitors
Company Period LTM YoY 3-year CAGR
SNDLSNDL Inc.LTM Mar 2026259.55M -1.2%+3.9%
ESPREsperion Therapeutics, Inc.LTM Mar 2026220.76M +13.9%+46.3%
CMPXCompass Therapeutics, Inc.LTM Mar 2026161.95M +17.8%+14.5%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026127.11M -2.8%-0.9%
SIGASIGA Technologies, Inc.LTM Mar 202671.58M +0.4%-0.6%
BCYCBicycle Therapeutics plcLTM Mar 202669.4M +7.1%+32.7%
EOLSEvolus, Inc.LTM Mar 202664.73M +3.0%+4.8%
EBSEmergent BioSolutions Inc.LTM Mar 202652.93M -1.2%+2.2%
VREXVarex Imaging CorporationLTM Apr 202641.7M +1.6%+1.3%
ANGOAngioDynamics, Inc.LTM Feb 202641.29M +1.4%+1.7%
MNPRMonopar Therapeutics Inc.LTM Mar 20267.34M -28.8%-16.5%
Peer median (excluding ORGO) 67.07M+1.5%+3.1%

Competitors are the stored peer set for ORGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue467.36M450.89M433.14M482.04M563.03M
Cost of Revenue114.2M105.02M106.48M115.74M137.52M
Gross Profit353.16M345.87M326.66M366.3M425.51M
Gross Margin75.6%76.7%75.4%76.0%75.6%
Research & Development30.74M39.76M44.38M50.27M44.54M
Selling, General & Admin250.2M283.81M269.75M294.51M326.24M
Operating Expenses280.94M323.57M314.13M367.59M369.64M
Depreciation & Amortization16.68M18.03M23.45M17.03M26.94M
EBITDA87M40.32M36.03M15.76M73.91M
EBITDA Margin18.6%8.9%8.3%3.3%13.1%
Operating Income72.22M22.3M12.53M(1.28M)55.87M
Operating Margin15.5%4.9%2.9%-0.3%9.9%
Interest Income00002.28M
Interest Expense7.24M2.01M2.19M1.54M0
Other Income / Expenses(9.13M)(2.02M)(2.13M)(1.52M)(8.9M)
Income Before Tax63.09M20.28M10.39M(2.81M)46.97M
Pre-Tax Margin13.5%4.5%2.4%-0.6%8.3%
Income Tax Expense(31.12M)4.75M5.45M(3.67M)9.94M
Net Income94.2M15.53M4.95M861K37.03M
Net Margin20.2%3.4%1.1%0.2%6.6%
EPS (Basic)0.730.120.04(0.01)0.16
EPS (Diluted)0.700.120.04(0.01)0.15
Weighted Avg Shares128.33M130.07M131.23M131.67M126.74M
Weighted Avg Shares (Diluted)133.66M132.38M132.75M131.67M130.25M

Organogenesis Holdings Inc.

NASDAQ:ORGO

Intrinsic Alpha fair value

Locked

Current Price

$0.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.